Thought Leadership
 
Email Page
2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma
April 9, 2019
Jonathan Harris, Drew Hillier and Nisan Zaghi*
Westlaw Journal Pharmaceutical

Westlaw Journal Pharmaceutical published “2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma,” authored by Axinn partner Jonathan Harris and associates Drew Hillier and Nisan Zaghi*.

Click here to access the article. 

*At the time of this writing, Nisan Zaghi's admission to the New York bar is pending.